RYTHM, Inc.RYMEarnings & Financial Report
Nasdaq · Health Care · Agricultural Services
RYTHM, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for rare genetic endocrine and metabolic disorders with high unmet medical needs. It primarily operates in the U.S. market, targeting pediatric and adult patient segments that lack standard effective treatment options.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| RSLGH, LLC | 49.99% | 6.9M | — | 2024-11-13 |
| Raymond Nobu Chang | 38.01% | 1.1M | ▼ -3.35pp | 2024-11-29 |
| I-Tseng Jenny Chan | 0.00% | 1.7M | flat | 2024-11-29 |
| Alyeska Investment Group, L.P. | 0.00% | — | — | 2024-02-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.